Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_assertion type Assertion NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_head.
- NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_assertion description "[ABCG2 was preferentially expressed in highly chemoresistant hepatocellular carcinoma cancer stem cells (CSC) enriched with CD133.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_provenance.
- NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_assertion evidence source_evidence_literature NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_provenance.
- NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_assertion SIO_000772 24130050 NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_provenance.
- NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_assertion wasDerivedFrom befree-20150227 NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_provenance.
- NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_assertion wasGeneratedBy ECO_0000203 NP823620.RA8hLcd_iCgOu2ae0Ua3vmjlrt3EUxmrs5Jo9DFXY0lgU130_provenance.